KeriCure Medical
KeriCure Medical is a woman-owned biotechnology company based in Tampa, FL, dedicated to providing advanced skin and wound care products to military and civilians. Since 2014, the company has provided advanced wound care to consumers, hospitals, military personnel and animals, helping to prevent infections and enhance wound healing. KeriCure's nanopolymer platform technology is optimally positioned for robust wound care that is simple, multi-use and effective.
Industries
Nr. of Employees
small (1-50)
KeriCure Medical
KeriCure Medical is currently seeking investment
KeriCure Medical is seeking a series-a investment in the range of 1m-5m
Products
Field Shield Wound Dressing
Field Shield is a sprayable nanopolymer wound dressing containing antimicrobial silver hydrosol and pain relieving lidocaine for an all-in-one burn and wound care solution. Ideal for masscal and prolonged field care, the multi-use spray can treat multiple wounds from a single, small format bottle that's ruggedized for austere wound care. Treat complex traumatic wounds and burns quickly and easily with little to no training.
Topical antiseptic wound wash (biofilm-disrupting)
A topical wound wash supplied as a spray that contains antimicrobial agents and is reported to disrupt established biofilms and reduce microbes rapidly.
Field Shield Wound Dressing
Field Shield is a sprayable nanopolymer wound dressing containing antimicrobial silver hydrosol and pain relieving lidocaine for an all-in-one burn and wound care solution. Ideal for masscal and prolonged field care, the multi-use spray can treat multiple wounds from a single, small format bottle that's ruggedized for austere wound care. Treat complex traumatic wounds and burns quickly and easily with little to no training.
Topical antiseptic wound wash (biofilm-disrupting)
A topical wound wash supplied as a spray that contains antimicrobial agents and is reported to disrupt established biofilms and reduce microbes rapidly.
Expertise Areas
- Advanced wound care and topical barrier technologies
- Topical antiseptics and wound cleansing
- Sprayable liquid bandage formulation and application
- Biofilm disruption testing for topical products
Key Technologies
- Sprayable elastic nanopolymer films
- Topical antiseptic formulations
- Biofilm-disruption assays
- Moisture-balancing wound dressings
Investors
Quake Capital Partners
$200,000 funded.
Announced on 2018-11-01.
Seed Round - KeriCure
$800,000 funded.
Announced on 2013-06-10.
Florida Institute for the Commercialization of Florida Technology
$350,000 funded.
Announced on 2012-11-16.
Venture Round - KeriCure
$510,000 funded.
Announced on 2011-01-10.
Quake Capital Partners
$200,000 funded.
Announced on 2018-11-01.
Seed Round - KeriCure
$800,000 funded.
Announced on 2013-06-10.
Florida Institute for the Commercialization of Florida Technology
$350,000 funded.
Announced on 2012-11-16.
Venture Round - KeriCure
$510,000 funded.
Announced on 2011-01-10.